Trial intelligence / Profile preview

Udenafil for Microvascular Angina (UMPIRE)

NCT01769482Phase 4Unknown

Sponsor
Samsung Medical Center
Start
Dec 2011
Primary completion
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of udenafil in microvascular angina (MVA), sponsored by Samsung Medical Center. Status: unknown.

02

Drugs

udenafil
03

Conditions

microvascular angina (MVA)

Beyond the preview

Go deeper on NCT01769482.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01769482.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call